Denton Arthur
664 posts


$AIDR | $AIRDF 🥼💪⚕️
Rocket Doctor AI Inc. was selected for the Canadian Life Sciences Trade Mission to New York / New Jersey. globenewswire.com/news-release/2…
Access matters. Direct exposure to U.S. investors, payers, healthcare buyers, and strategic partners in one of the world’s largest healthcare markets. For an early-stage growth company, doors opening today can become contracts tomorrow.
English

@RabbittLeader @wave3trades How are you predicting their revenues? Discounting competition. Market cap based on promises not yet delivered
English

@DentonArthur2 @wave3trades Idiotic post. Stocks are valued using their future revenues not current. More accurately it is the future stream of net cash flows that are discounted to their present value = share price. You need to take a basic course in financial economics.
English

@IncomeSharks @MrMikeInvesting Whats the ones you are looking at?
English

@MrMikeInvesting Anyone chasing AI or Semis here instead of Rare Earths is missing an easy play
English

@1OF1STOCKS Just buy $hims. Everything set up for a rocket ship
English

@unknownasc @StockTrader_Max Disagree momentum is too powerful nvo pills do too well
English

@StockTrader_Max i thinking premarket tomorrow 2-3% green, ending the day in the red moving into the lower lows towards the end of the week.
English

$HIMS For those who are interested in the short term outlook for Hims, I still think that lower prices come next before the breakout higher towards +$40 a share 🎯
A pretty standard ABC correction in playing out here, we are likely in wave C of the correction and still need to post one more lower low to confirm this correction is complete 🤝🏼
Im looking for the gap to close from Friday's session, followed by an undercut of the lows at $27 a share from Thursday.
For those who are wanting to add more shares, the $25-$27 range is a great zone to buy, I still have some dry powder which I will look to put to work at this price zone..
Once this ABC correction is complete, +$40 prices come next for the wave 3 target🎯

English

@alc2022 Think you need to look at Aduro, pearler of a company
English

@rob_kopf @ProudSocialist When hunting a lion it costs maybe on average 50k which goes to funding the farm the workers the owners. This keeps game farms going. If there were no income there would be no farms meaning no animals.
English

@DentonArthur2 @ProudSocialist That hunter's going to have a lion sandwich is he??
English

@rob_kopf @ProudSocialist Do you ask lions to hinder themselves when they hunt?
English

@rob_kopf @ProudSocialist We are the apex predator dipshit. We evolved so we dont have to
English

@ProudSocialist I wonder how many POS hunters have the ba11s to hunt a bear with just one bullet. That would be too fair, wouldn't it??
English

@AbdelilahN33609 @Investinc_Intel What are you on about its already undervalued
English

@Investinc_Intel $HIMS best case scenario over 3-4 years still only gets you maybe 50-100% upside, not a 4x or 5x. the growth story is real but at $30 a lot is already priced in. what am i missing
English

@TinyToothDDS Yup just bought more thanks for the discount
English

Grafico diario de #SuperMicroComputer, alcanzo el Objetivo alcista 28,78€, el siguiente Objetivo es 34,94$.
Soporte 28,78$, si lo pierde podria corregir hasta la zona entre 25,71-19,48$
RSI 60 sigue en momento alcista
$SMCI

Español

Super Micro Computer fijó el precio de su oferta pública previamente anunciada de 2 millones de acciones ordinarias
#SuperMicroComputer, venderá los 2 millones de acciones a 875$ por acción, lo que se espera que aporte a la empresa 1750 millones$.
$SMCI 874,12$ -4,05%
Español

@T20SEtrading That go up 59 % a year? That has multiple vertices on the horizon? Telehealth the future by making it so convenient for people? Dont actually see too many others
English

@DentonArthur2 I see the potential and upside📈
but wouldn’t you agree there are higher-conviction opportunities elsewhere?🤑
English

BofA raised the firm’s price target on & Hers (HIMS) to $30 from $25 and keeps a Neutral rating on the shares. 👇
Amazon’s new offering in the GLP-1 market appears well suited for long-term GLP-1 subscribers that may opt to minimize ongoing costs, says the analyst, who anticipates it could further pressure Hims’ GLP-1 revenue in 2026 and beyond. The firm cites a raised multiple to reflect peptide optionality and peer multiple expansion, offset by yesterday morning’s Amazon news, for its news Hims target.

English













